Findings

What do systematic reviews say?

321 questions · 328 findings · 23 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 119 · 36.3%GRADE not reported 15 · 4.6%Very low 64 · 19.5%Low 72 · 22%Moderate 41 · 12.5%High 17 · 5.2%

NB‐UVB vs UVA1

Withdrawals due to adverse events · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 13 participants
Very low

NB‐UVB vs PUVA

Physician‐assessed changes in clinical signs · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

NB‐UVB vs PUVA

Patient‐reported changes in symptoms ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs PUVA

Investigator Global Assessment · atopic eczema

It is very uncertain whether summary of findings table ‐ NB‐UVB changes investigator Global Assessment compared with PUVA (very low certainty).

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
OR 1 [0.13, 7.89]
1 study · 20 participants
Very low

NB‐UVB vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs PUVA

Withdrawals due to adverse events · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

UVA1 vs PUVA

Physician‐assessed changes in clinical signs · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Very low

UVA1 vs PUVA

Patient‐reported changes in symptoms ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

UVA1 vs PUVA

Investigator Global Assessment ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

UVA1 vs PUVA

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs placebo

Patient‐reported changes in symptoms · atopic eczema

Summary of findings table ‐ NB‐UVB may leads to higher patient‐reported changes in symptoms compared with placebo (low certainty).

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
RR 1.72 [1.1, 2.69]
1 study · 40 participants
Low

UVA1 vs PUVA

Withdrawals due to adverse events not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs placebo

Investigator Global Assessment · atopic eczema

Summary of findings table ‐ NB‐UVB may leads to higher investigator Global Assessment (short‐term) compared with placebo (low certainty).

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
RR 2.81 [1.1, 7.17]
1 study · 41 participants
Low

NB‐UVB vs placebo

Health‐related quality of life ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs placebo

Withdrawals due to adverse outcomes · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 89 participants
Low

NB‐UVB vs UVA1

Physician‐assessed changes in clinical signs · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Very low

NB‐UVB vs UVA1

Patient‐reported changes in symptoms · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Very low

NB‐UVB vs UVA1

Investigator Global Assessment ‐ not measured · atopic eczema

The review found no eligible studies for this question.

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NB‐UVB vs UVA1

Health‐related quality of life · atopic eczema

1 finding from 1 review

Phototherapy for atopic eczema 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Very low

Cetirizine 0.5 mg/kg/d vs placebo (18‐month intervention)

Pruritus · children with eczema

The review found no eligible studies for this question.

1 finding from 1 review

Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found